nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP1B1—Mitoxantrone—multiple sclerosis	0.137	0.204	CbGbCtD
Theophylline—CYP2E1—Fingolimod—multiple sclerosis	0.099	0.147	CbGbCtD
Theophylline—CYP1B1—Dexamethasone—multiple sclerosis	0.0712	0.106	CbGbCtD
Theophylline—SLC22A7—Methotrexate—multiple sclerosis	0.0517	0.077	CbGbCtD
Theophylline—CYP2D6—Fingolimod—multiple sclerosis	0.0472	0.0701	CbGbCtD
Theophylline—CYP2E1—Mitoxantrone—multiple sclerosis	0.0465	0.0692	CbGbCtD
Theophylline—CYP1A1—Dexamethasone—multiple sclerosis	0.0312	0.0464	CbGbCtD
Theophylline—CYP3A4—Fingolimod—multiple sclerosis	0.03	0.0446	CbGbCtD
Theophylline—CYP2E1—Dexamethasone—multiple sclerosis	0.0241	0.0359	CbGbCtD
Theophylline—CYP3A4—Methylprednisolone—multiple sclerosis	0.0193	0.0287	CbGbCtD
Theophylline—CYP2C8—Dexamethasone—multiple sclerosis	0.018	0.0268	CbGbCtD
Theophylline—CYP3A4—Triamcinolone—multiple sclerosis	0.0146	0.0218	CbGbCtD
Theophylline—CYP3A4—Mitoxantrone—multiple sclerosis	0.0141	0.021	CbGbCtD
Theophylline—CYP2C9—Dexamethasone—multiple sclerosis	0.0126	0.0187	CbGbCtD
Theophylline—CYP3A4—Betamethasone—multiple sclerosis	0.0126	0.0187	CbGbCtD
Theophylline—CYP3A4—Prednisolone—multiple sclerosis	0.0124	0.0184	CbGbCtD
Theophylline—CYP3A4—Prednisone—multiple sclerosis	0.0117	0.0174	CbGbCtD
Theophylline—CYP2D6—Dexamethasone—multiple sclerosis	0.0115	0.0171	CbGbCtD
Theophylline—CYP3A4—Dexamethasone—multiple sclerosis	0.00731	0.0109	CbGbCtD
Theophylline—ADORA1—nerve—multiple sclerosis	0.00407	0.059	CbGeAlD
Theophylline—PDE4C—brainstem—multiple sclerosis	0.00278	0.0403	CbGeAlD
Theophylline—PDE5A—retina—multiple sclerosis	0.00178	0.0258	CbGeAlD
Theophylline—PDE4C—midbrain—multiple sclerosis	0.00177	0.0257	CbGeAlD
Theophylline—HDAC2—brainstem—multiple sclerosis	0.00173	0.025	CbGeAlD
Theophylline—HDAC2—retina—multiple sclerosis	0.00167	0.0241	CbGeAlD
Theophylline—PDE4C—nervous system—multiple sclerosis	0.00146	0.0211	CbGeAlD
Theophylline—PDE3B—cerebellum—multiple sclerosis	0.00145	0.021	CbGeAlD
Theophylline—PDE4C—central nervous system—multiple sclerosis	0.0014	0.0203	CbGeAlD
Theophylline—ADORA2B—nervous system—multiple sclerosis	0.00127	0.0185	CbGeAlD
Theophylline—ADORA2A—spinal cord—multiple sclerosis	0.00126	0.0182	CbGeAlD
Theophylline—ADORA2B—central nervous system—multiple sclerosis	0.00123	0.0178	CbGeAlD
Theophylline—ADORA1—medulla oblongata—multiple sclerosis	0.00122	0.0177	CbGeAlD
Theophylline—PDE4D—cerebellum—multiple sclerosis	0.00121	0.0175	CbGeAlD
Theophylline—HDAC2—medulla oblongata—multiple sclerosis	0.0012	0.0174	CbGeAlD
Theophylline—ADORA2B—cerebellum—multiple sclerosis	0.0012	0.0174	CbGeAlD
Theophylline—PDE3B—brain—multiple sclerosis	0.00118	0.017	CbGeAlD
Theophylline—ADA—nervous system—multiple sclerosis	0.00117	0.0169	CbGeAlD
Theophylline—ADA—central nervous system—multiple sclerosis	0.00112	0.0163	CbGeAlD
Theophylline—PDE4C—brain—multiple sclerosis	0.00111	0.0161	CbGeAlD
Theophylline—ADORA1—midbrain—multiple sclerosis	0.00111	0.0161	CbGeAlD
Theophylline—HDAC2—midbrain—multiple sclerosis	0.0011	0.0159	CbGeAlD
Theophylline—ADORA1—spinal cord—multiple sclerosis	0.00109	0.0157	CbGeAlD
Theophylline—PDE4A—cerebellum—multiple sclerosis	0.00107	0.0155	CbGeAlD
Theophylline—ADORA2A—nervous system—multiple sclerosis	0.00106	0.0154	CbGeAlD
Theophylline—ADORA2A—central nervous system—multiple sclerosis	0.00102	0.0148	CbGeAlD
Theophylline—ADORA2A—cerebellum—multiple sclerosis	0.000998	0.0145	CbGeAlD
Theophylline—PDE4D—brain—multiple sclerosis	0.000981	0.0142	CbGeAlD
Theophylline—ADORA2B—brain—multiple sclerosis	0.000974	0.0141	CbGeAlD
Theophylline—PDE5A—nervous system—multiple sclerosis	0.000966	0.014	CbGeAlD
Theophylline—PDE5A—central nervous system—multiple sclerosis	0.00093	0.0135	CbGeAlD
Theophylline—ADORA1—nervous system—multiple sclerosis	0.000916	0.0133	CbGeAlD
Theophylline—PDE5A—cerebellum—multiple sclerosis	0.000909	0.0132	CbGeAlD
Theophylline—HDAC2—nervous system—multiple sclerosis	0.000905	0.0131	CbGeAlD
Theophylline—PDE4B—medulla oblongata—multiple sclerosis	0.000902	0.0131	CbGeAlD
Theophylline—ADA—brain—multiple sclerosis	0.000891	0.0129	CbGeAlD
Theophylline—PDE3A—cerebellum—multiple sclerosis	0.000884	0.0128	CbGeAlD
Theophylline—ADORA1—central nervous system—multiple sclerosis	0.000882	0.0128	CbGeAlD
Theophylline—HDAC2—central nervous system—multiple sclerosis	0.000871	0.0126	CbGeAlD
Theophylline—PDE4A—brain—multiple sclerosis	0.000868	0.0126	CbGeAlD
Theophylline—ADORA1—cerebellum—multiple sclerosis	0.000862	0.0125	CbGeAlD
Theophylline—HDAC2—cerebellum—multiple sclerosis	0.000851	0.0123	CbGeAlD
Theophylline—PDE4B—midbrain—multiple sclerosis	0.000824	0.0119	CbGeAlD
Theophylline—Extravasation—Betamethasone—multiple sclerosis	0.000811	0.00753	CcSEcCtD
Theophylline—Extravasation—Dexamethasone—multiple sclerosis	0.000811	0.00753	CcSEcCtD
Theophylline—ADORA2A—brain—multiple sclerosis	0.000811	0.0117	CbGeAlD
Theophylline—PDE4B—spinal cord—multiple sclerosis	0.000804	0.0116	CbGeAlD
Theophylline—SLC22A7—brain—multiple sclerosis	0.000803	0.0116	CbGeAlD
Theophylline—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.000776	0.00719	CcSEcCtD
Theophylline—Dermatitis contact—Triamcinolone—multiple sclerosis	0.000771	0.00715	CcSEcCtD
Theophylline—Haematemesis—Methotrexate—multiple sclerosis	0.000742	0.00688	CcSEcCtD
Theophylline—PDE5A—brain—multiple sclerosis	0.000738	0.0107	CbGeAlD
Theophylline—PDE3A—brain—multiple sclerosis	0.000718	0.0104	CbGeAlD
Theophylline—Arrhythmia—Cladribine—multiple sclerosis	0.000706	0.00655	CcSEcCtD
Theophylline—Pruritus—Fingolimod—multiple sclerosis	0.000701	0.0065	CcSEcCtD
Theophylline—ADORA1—brain—multiple sclerosis	0.0007	0.0101	CbGeAlD
Theophylline—Dermatitis contact—Dexamethasone—multiple sclerosis	0.0007	0.00649	CcSEcCtD
Theophylline—Dermatitis contact—Betamethasone—multiple sclerosis	0.0007	0.00649	CcSEcCtD
Theophylline—Alopecia—Cladribine—multiple sclerosis	0.000698	0.00648	CcSEcCtD
Theophylline—HDAC2—brain—multiple sclerosis	0.000691	0.01	CbGeAlD
Theophylline—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.000686	0.00636	CcSEcCtD
Theophylline—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.000683	0.00634	CcSEcCtD
Theophylline—Diarrhoea—Fingolimod—multiple sclerosis	0.000678	0.00628	CcSEcCtD
Theophylline—PDE4B—nervous system—multiple sclerosis	0.000677	0.00981	CbGeAlD
Theophylline—Dizziness—Fingolimod—multiple sclerosis	0.000655	0.00607	CcSEcCtD
Theophylline—PDE4B—central nervous system—multiple sclerosis	0.000652	0.00945	CbGeAlD
Theophylline—PDE4B—cerebellum—multiple sclerosis	0.000637	0.00923	CbGeAlD
Theophylline—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000636	0.0059	CcSEcCtD
Theophylline—Headache—Fingolimod—multiple sclerosis	0.00062	0.00575	CcSEcCtD
Theophylline—Extravasation—Methotrexate—multiple sclerosis	0.000591	0.00548	CcSEcCtD
Theophylline—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.000585	0.00543	CcSEcCtD
Theophylline—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000585	0.00543	CcSEcCtD
Theophylline—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000584	0.00542	CcSEcCtD
Theophylline—Anxiety—Cladribine—multiple sclerosis	0.000584	0.00541	CcSEcCtD
Theophylline—CYP1B1—nervous system—multiple sclerosis	0.000581	0.00841	CbGeAlD
Theophylline—Arrhythmia—Azathioprine—multiple sclerosis	0.000574	0.00532	CcSEcCtD
Theophylline—Alopecia—Azathioprine—multiple sclerosis	0.000568	0.00527	CcSEcCtD
Theophylline—CYP2D6—brainstem—multiple sclerosis	0.000566	0.00819	CbGeAlD
Theophylline—CYP1B1—central nervous system—multiple sclerosis	0.000559	0.00809	CbGeAlD
Theophylline—Infection—Cladribine—multiple sclerosis	0.000558	0.00517	CcSEcCtD
Theophylline—Hyperuricaemia—Methotrexate—multiple sclerosis	0.000555	0.00515	CcSEcCtD
Theophylline—Haematuria—Mitoxantrone—multiple sclerosis	0.000552	0.00512	CcSEcCtD
Theophylline—Nervous system disorder—Cladribine—multiple sclerosis	0.000551	0.00511	CcSEcCtD
Theophylline—Tachycardia—Cladribine—multiple sclerosis	0.000548	0.00508	CcSEcCtD
Theophylline—CYP1B1—cerebellum—multiple sclerosis	0.000546	0.00791	CbGeAlD
Theophylline—Irritability—Methylprednisolone—multiple sclerosis	0.000539	0.005	CcSEcCtD
Theophylline—Anorexia—Cladribine—multiple sclerosis	0.000535	0.00496	CcSEcCtD
Theophylline—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000531	0.00493	CcSEcCtD
Theophylline—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000531	0.00493	CcSEcCtD
Theophylline—Blood uric acid increased—Methotrexate—multiple sclerosis	0.000525	0.00487	CcSEcCtD
Theophylline—Hypotension—Cladribine—multiple sclerosis	0.000525	0.00487	CcSEcCtD
Theophylline—PDE4B—brain—multiple sclerosis	0.000518	0.0075	CbGeAlD
Theophylline—Insomnia—Cladribine—multiple sclerosis	0.000508	0.00471	CcSEcCtD
Theophylline—CYP2E1—medulla oblongata—multiple sclerosis	0.000498	0.00721	CbGeAlD
Theophylline—Irritability—Dexamethasone—multiple sclerosis	0.000491	0.00455	CcSEcCtD
Theophylline—Irritability—Betamethasone—multiple sclerosis	0.000491	0.00455	CcSEcCtD
Theophylline—Decreased appetite—Cladribine—multiple sclerosis	0.000488	0.00453	CcSEcCtD
Theophylline—Coma—Methotrexate—multiple sclerosis	0.000471	0.00437	CcSEcCtD
Theophylline—Hypokalaemia—Betamethasone—multiple sclerosis	0.000468	0.00434	CcSEcCtD
Theophylline—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000468	0.00434	CcSEcCtD
Theophylline—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000464	0.0043	CcSEcCtD
Theophylline—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000459	0.00426	CcSEcCtD
Theophylline—Alopecia—Mitoxantrone—multiple sclerosis	0.000459	0.00426	CcSEcCtD
Theophylline—Infection—Azathioprine—multiple sclerosis	0.000453	0.00421	CcSEcCtD
Theophylline—Urticaria—Cladribine—multiple sclerosis	0.000446	0.00414	CcSEcCtD
Theophylline—CYP2E1—spinal cord—multiple sclerosis	0.000444	0.00643	CbGeAlD
Theophylline—Body temperature increased—Cladribine—multiple sclerosis	0.000444	0.00412	CcSEcCtD
Theophylline—Abdominal pain—Cladribine—multiple sclerosis	0.000444	0.00412	CcSEcCtD
Theophylline—CYP1B1—brain—multiple sclerosis	0.000444	0.00643	CbGeAlD
Theophylline—Irritability—Prednisone—multiple sclerosis	0.000427	0.00396	CcSEcCtD
Theophylline—Hypotension—Azathioprine—multiple sclerosis	0.000427	0.00396	CcSEcCtD
Theophylline—Polyuria—Methotrexate—multiple sclerosis	0.000426	0.00395	CcSEcCtD
Theophylline—Hypersensitivity—Cladribine—multiple sclerosis	0.000414	0.00384	CcSEcCtD
Theophylline—CYP1A1—nervous system—multiple sclerosis	0.00041	0.00594	CbGeAlD
Theophylline—Hypokalaemia—Prednisone—multiple sclerosis	0.000407	0.00378	CcSEcCtD
Theophylline—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000401	0.00372	CcSEcCtD
Theophylline—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000401	0.00372	CcSEcCtD
Theophylline—Pruritus—Cladribine—multiple sclerosis	0.000397	0.00368	CcSEcCtD
Theophylline—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000396	0.00368	CcSEcCtD
Theophylline—CYP1A1—central nervous system—multiple sclerosis	0.000395	0.00572	CbGeAlD
Theophylline—Convulsion—Mitoxantrone—multiple sclerosis	0.000392	0.00363	CcSEcCtD
Theophylline—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000386	0.00358	CcSEcCtD
Theophylline—Diarrhoea—Cladribine—multiple sclerosis	0.000384	0.00356	CcSEcCtD
Theophylline—Anxiety—Mitoxantrone—multiple sclerosis	0.000384	0.00356	CcSEcCtD
Theophylline—Arrhythmia—Prednisolone—multiple sclerosis	0.000381	0.00353	CcSEcCtD
Theophylline—CYP2E1—nervous system—multiple sclerosis	0.000374	0.00542	CbGeAlD
Theophylline—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000373	0.00346	CcSEcCtD
Theophylline—Dizziness—Cladribine—multiple sclerosis	0.000371	0.00344	CcSEcCtD
Theophylline—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000369	0.00342	CcSEcCtD
Theophylline—Infection—Mitoxantrone—multiple sclerosis	0.000367	0.0034	CcSEcCtD
Theophylline—Shock—Mitoxantrone—multiple sclerosis	0.000363	0.00337	CcSEcCtD
Theophylline—Body temperature increased—Azathioprine—multiple sclerosis	0.000361	0.00335	CcSEcCtD
Theophylline—Abdominal pain—Azathioprine—multiple sclerosis	0.000361	0.00335	CcSEcCtD
Theophylline—CYP2E1—central nervous system—multiple sclerosis	0.00036	0.00522	CbGeAlD
Theophylline—Tachycardia—Mitoxantrone—multiple sclerosis	0.00036	0.00334	CcSEcCtD
Theophylline—Irritability—Methotrexate—multiple sclerosis	0.000357	0.00331	CcSEcCtD
Theophylline—Vomiting—Cladribine—multiple sclerosis	0.000357	0.00331	CcSEcCtD
Theophylline—Rash—Cladribine—multiple sclerosis	0.000354	0.00328	CcSEcCtD
Theophylline—Dermatitis—Cladribine—multiple sclerosis	0.000354	0.00328	CcSEcCtD
Theophylline—CYP2E1—cerebellum—multiple sclerosis	0.000352	0.0051	CbGeAlD
Theophylline—Anorexia—Mitoxantrone—multiple sclerosis	0.000352	0.00326	CcSEcCtD
Theophylline—Headache—Cladribine—multiple sclerosis	0.000352	0.00326	CcSEcCtD
Theophylline—Arrhythmia—Triamcinolone—multiple sclerosis	0.00035	0.00325	CcSEcCtD
Theophylline—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000349	0.00324	CcSEcCtD
Theophylline—Hyperglycaemia—Prednisone—multiple sclerosis	0.000349	0.00324	CcSEcCtD
Theophylline—Hypotension—Mitoxantrone—multiple sclerosis	0.000345	0.0032	CcSEcCtD
Theophylline—CYP2C8—brain—multiple sclerosis	0.00034	0.00492	CbGeAlD
Theophylline—Hypersensitivity—Azathioprine—multiple sclerosis	0.000336	0.00312	CcSEcCtD
Theophylline—Nausea—Cladribine—multiple sclerosis	0.000333	0.00309	CcSEcCtD
Theophylline—Convulsion—Prednisolone—multiple sclerosis	0.000321	0.00298	CcSEcCtD
Theophylline—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000321	0.00298	CcSEcCtD
Theophylline—Arrhythmia—Dexamethasone—multiple sclerosis	0.000318	0.00295	CcSEcCtD
Theophylline—Arrhythmia—Betamethasone—multiple sclerosis	0.000318	0.00295	CcSEcCtD
Theophylline—Alopecia—Betamethasone—multiple sclerosis	0.000314	0.00291	CcSEcCtD
Theophylline—Alopecia—Dexamethasone—multiple sclerosis	0.000314	0.00291	CcSEcCtD
Theophylline—CYP1A1—brain—multiple sclerosis	0.000314	0.00454	CbGeAlD
Theophylline—Diarrhoea—Azathioprine—multiple sclerosis	0.000312	0.0029	CcSEcCtD
Theophylline—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000303	0.00281	CcSEcCtD
Theophylline—Dizziness—Azathioprine—multiple sclerosis	0.000302	0.0028	CcSEcCtD
Theophylline—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000302	0.0028	CcSEcCtD
Theophylline—CYP3A4—nervous system—multiple sclerosis	0.000301	0.00436	CbGeAlD
Theophylline—Shock—Prednisolone—multiple sclerosis	0.000298	0.00276	CcSEcCtD
Theophylline—CYP2D6—nervous system—multiple sclerosis	0.000296	0.00429	CbGeAlD
Theophylline—Convulsion—Triamcinolone—multiple sclerosis	0.000296	0.00274	CcSEcCtD
Theophylline—Tachycardia—Prednisolone—multiple sclerosis	0.000295	0.00274	CcSEcCtD
Theophylline—Convulsion—Methylprednisolone—multiple sclerosis	0.000295	0.00274	CcSEcCtD
Theophylline—Urticaria—Mitoxantrone—multiple sclerosis	0.000293	0.00272	CcSEcCtD
Theophylline—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000292	0.00271	CcSEcCtD
Theophylline—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000292	0.00271	CcSEcCtD
Theophylline—Vomiting—Azathioprine—multiple sclerosis	0.00029	0.00269	CcSEcCtD
Theophylline—CYP3A4—central nervous system—multiple sclerosis	0.00029	0.0042	CbGeAlD
Theophylline—Anxiety—Methylprednisolone—multiple sclerosis	0.000289	0.00268	CcSEcCtD
Theophylline—Rash—Azathioprine—multiple sclerosis	0.000288	0.00267	CcSEcCtD
Theophylline—Dermatitis—Azathioprine—multiple sclerosis	0.000288	0.00267	CcSEcCtD
Theophylline—Flushing—Prednisone—multiple sclerosis	0.000287	0.00267	CcSEcCtD
Theophylline—CYP2E1—brain—multiple sclerosis	0.000286	0.00414	CbGeAlD
Theophylline—Headache—Azathioprine—multiple sclerosis	0.000286	0.00265	CcSEcCtD
Theophylline—CYP2D6—central nervous system—multiple sclerosis	0.000285	0.00413	CbGeAlD
Theophylline—CYP2D6—cerebellum—multiple sclerosis	0.000279	0.00404	CbGeAlD
Theophylline—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000278	0.00258	CcSEcCtD
Theophylline—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000278	0.00258	CcSEcCtD
Theophylline—Arrhythmia—Prednisone—multiple sclerosis	0.000277	0.00257	CcSEcCtD
Theophylline—Infection—Triamcinolone—multiple sclerosis	0.000277	0.00257	CcSEcCtD
Theophylline—Infection—Methylprednisolone—multiple sclerosis	0.000276	0.00256	CcSEcCtD
Theophylline—Haematuria—Methotrexate—multiple sclerosis	0.000275	0.00255	CcSEcCtD
Theophylline—Shock—Triamcinolone—multiple sclerosis	0.000274	0.00254	CcSEcCtD
Theophylline—Insomnia—Prednisolone—multiple sclerosis	0.000274	0.00254	CcSEcCtD
Theophylline—Alopecia—Prednisone—multiple sclerosis	0.000274	0.00254	CcSEcCtD
Theophylline—Shock—Methylprednisolone—multiple sclerosis	0.000273	0.00253	CcSEcCtD
Theophylline—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000272	0.00253	CcSEcCtD
Theophylline—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000272	0.00252	CcSEcCtD
Theophylline—Tachycardia—Triamcinolone—multiple sclerosis	0.000272	0.00252	CcSEcCtD
Theophylline—Nausea—Azathioprine—multiple sclerosis	0.000271	0.00251	CcSEcCtD
Theophylline—Tachycardia—Methylprednisolone—multiple sclerosis	0.000271	0.00251	CcSEcCtD
Theophylline—Convulsion—Dexamethasone—multiple sclerosis	0.000268	0.00249	CcSEcCtD
Theophylline—Convulsion—Betamethasone—multiple sclerosis	0.000268	0.00249	CcSEcCtD
Theophylline—Anxiety—Betamethasone—multiple sclerosis	0.000263	0.00244	CcSEcCtD
Theophylline—Anxiety—Dexamethasone—multiple sclerosis	0.000263	0.00244	CcSEcCtD
Theophylline—Hypotension—Methylprednisolone—multiple sclerosis	0.00026	0.00241	CcSEcCtD
Theophylline—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000253	0.00234	CcSEcCtD
Theophylline—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000253	0.00234	CcSEcCtD
Theophylline—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000252	0.00234	CcSEcCtD
Theophylline—Insomnia—Triamcinolone—multiple sclerosis	0.000252	0.00234	CcSEcCtD
Theophylline—Insomnia—Methylprednisolone—multiple sclerosis	0.000251	0.00233	CcSEcCtD
Theophylline—Infection—Dexamethasone—multiple sclerosis	0.000251	0.00233	CcSEcCtD
Theophylline—Infection—Betamethasone—multiple sclerosis	0.000251	0.00233	CcSEcCtD
Theophylline—Shock—Dexamethasone—multiple sclerosis	0.000249	0.0023	CcSEcCtD
Theophylline—Shock—Betamethasone—multiple sclerosis	0.000249	0.0023	CcSEcCtD
Theophylline—Nervous system disorder—Betamethasone—multiple sclerosis	0.000248	0.0023	CcSEcCtD
Theophylline—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000248	0.0023	CcSEcCtD
Theophylline—Agitation—Prednisone—multiple sclerosis	0.000248	0.0023	CcSEcCtD
Theophylline—Tachycardia—Betamethasone—multiple sclerosis	0.000247	0.00229	CcSEcCtD
Theophylline—Tachycardia—Dexamethasone—multiple sclerosis	0.000247	0.00229	CcSEcCtD
Theophylline—Anorexia—Dexamethasone—multiple sclerosis	0.000241	0.00223	CcSEcCtD
Theophylline—Anorexia—Betamethasone—multiple sclerosis	0.000241	0.00223	CcSEcCtD
Theophylline—Urticaria—Prednisolone—multiple sclerosis	0.00024	0.00223	CcSEcCtD
Theophylline—Hypotension—Dexamethasone—multiple sclerosis	0.000236	0.00219	CcSEcCtD
Theophylline—Hypotension—Betamethasone—multiple sclerosis	0.000236	0.00219	CcSEcCtD
Theophylline—Vomiting—Mitoxantrone—multiple sclerosis	0.000235	0.00218	CcSEcCtD
Theophylline—Convulsion—Prednisone—multiple sclerosis	0.000234	0.00217	CcSEcCtD
Theophylline—Rash—Mitoxantrone—multiple sclerosis	0.000233	0.00216	CcSEcCtD
Theophylline—Dermatitis—Mitoxantrone—multiple sclerosis	0.000232	0.00216	CcSEcCtD
Theophylline—Headache—Mitoxantrone—multiple sclerosis	0.000231	0.00214	CcSEcCtD
Theophylline—Anxiety—Prednisone—multiple sclerosis	0.000229	0.00212	CcSEcCtD
Theophylline—Alopecia—Methotrexate—multiple sclerosis	0.000229	0.00212	CcSEcCtD
Theophylline—Insomnia—Betamethasone—multiple sclerosis	0.000228	0.00212	CcSEcCtD
Theophylline—Insomnia—Dexamethasone—multiple sclerosis	0.000228	0.00212	CcSEcCtD
Theophylline—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000227	0.00211	CcSEcCtD
Theophylline—CYP2D6—brain—multiple sclerosis	0.000227	0.00328	CbGeAlD
Theophylline—Hypersensitivity—Prednisolone—multiple sclerosis	0.000223	0.00207	CcSEcCtD
Theophylline—Urticaria—Triamcinolone—multiple sclerosis	0.000221	0.00205	CcSEcCtD
Theophylline—Urticaria—Methylprednisolone—multiple sclerosis	0.000221	0.00205	CcSEcCtD
Theophylline—Body temperature increased—Triamcinolone—multiple sclerosis	0.00022	0.00204	CcSEcCtD
Theophylline—Anaphylactic shock—Prednisone—multiple sclerosis	0.00022	0.00204	CcSEcCtD
Theophylline—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00022	0.00204	CcSEcCtD
Theophylline—Decreased appetite—Dexamethasone—multiple sclerosis	0.00022	0.00204	CcSEcCtD
Theophylline—Decreased appetite—Betamethasone—multiple sclerosis	0.00022	0.00204	CcSEcCtD
Theophylline—Nausea—Mitoxantrone—multiple sclerosis	0.000219	0.00203	CcSEcCtD
Theophylline—Infection—Prednisone—multiple sclerosis	0.000219	0.00203	CcSEcCtD
Theophylline—Shock—Prednisone—multiple sclerosis	0.000216	0.00201	CcSEcCtD
Theophylline—Nervous system disorder—Prednisone—multiple sclerosis	0.000216	0.002	CcSEcCtD
Theophylline—Tachycardia—Prednisone—multiple sclerosis	0.000215	0.00199	CcSEcCtD
Theophylline—Anorexia—Prednisone—multiple sclerosis	0.00021	0.00194	CcSEcCtD
Theophylline—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000207	0.00192	CcSEcCtD
Theophylline—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000207	0.00192	CcSEcCtD
Theophylline—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000205	0.0019	CcSEcCtD
Theophylline—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000205	0.0019	CcSEcCtD
Theophylline—Urticaria—Betamethasone—multiple sclerosis	0.000201	0.00186	CcSEcCtD
Theophylline—Urticaria—Dexamethasone—multiple sclerosis	0.000201	0.00186	CcSEcCtD
Theophylline—Dizziness—Prednisolone—multiple sclerosis	0.0002	0.00186	CcSEcCtD
Theophylline—Body temperature increased—Dexamethasone—multiple sclerosis	0.0002	0.00185	CcSEcCtD
Theophylline—Body temperature increased—Betamethasone—multiple sclerosis	0.0002	0.00185	CcSEcCtD
Theophylline—Abdominal pain—Betamethasone—multiple sclerosis	0.0002	0.00185	CcSEcCtD
Theophylline—Abdominal pain—Dexamethasone—multiple sclerosis	0.0002	0.00185	CcSEcCtD
Theophylline—Insomnia—Prednisone—multiple sclerosis	0.000199	0.00185	CcSEcCtD
Theophylline—Pruritus—Triamcinolone—multiple sclerosis	0.000197	0.00183	CcSEcCtD
Theophylline—Pruritus—Methylprednisolone—multiple sclerosis	0.000197	0.00182	CcSEcCtD
Theophylline—Convulsion—Methotrexate—multiple sclerosis	0.000195	0.00181	CcSEcCtD
Theophylline—Decreased appetite—Prednisone—multiple sclerosis	0.000191	0.00177	CcSEcCtD
Theophylline—Rash—Prednisolone—multiple sclerosis	0.000191	0.00177	CcSEcCtD
Theophylline—Dermatitis—Prednisolone—multiple sclerosis	0.000191	0.00177	CcSEcCtD
Theophylline—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00019	0.00176	CcSEcCtD
Theophylline—Headache—Prednisolone—multiple sclerosis	0.00019	0.00176	CcSEcCtD
Theophylline—Dizziness—Triamcinolone—multiple sclerosis	0.000184	0.00171	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000184	0.00171	CcSEcCtD
Theophylline—Dizziness—Methylprednisolone—multiple sclerosis	0.000184	0.0017	CcSEcCtD
Theophylline—Infection—Methotrexate—multiple sclerosis	0.000183	0.00169	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—multiple sclerosis	0.00018	0.00167	CcSEcCtD
Theophylline—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00018	0.00167	CcSEcCtD
Theophylline—Nausea—Prednisolone—multiple sclerosis	0.00018	0.00167	CcSEcCtD
Theophylline—Pruritus—Dexamethasone—multiple sclerosis	0.000179	0.00166	CcSEcCtD
Theophylline—Pruritus—Betamethasone—multiple sclerosis	0.000179	0.00166	CcSEcCtD
Theophylline—Vomiting—Triamcinolone—multiple sclerosis	0.000177	0.00164	CcSEcCtD
Theophylline—Vomiting—Methylprednisolone—multiple sclerosis	0.000177	0.00164	CcSEcCtD
Theophylline—Rash—Triamcinolone—multiple sclerosis	0.000176	0.00163	CcSEcCtD
Theophylline—Dermatitis—Triamcinolone—multiple sclerosis	0.000175	0.00163	CcSEcCtD
Theophylline—Anorexia—Methotrexate—multiple sclerosis	0.000175	0.00163	CcSEcCtD
Theophylline—Rash—Methylprednisolone—multiple sclerosis	0.000175	0.00162	CcSEcCtD
Theophylline—Dermatitis—Methylprednisolone—multiple sclerosis	0.000175	0.00162	CcSEcCtD
Theophylline—Urticaria—Prednisone—multiple sclerosis	0.000175	0.00162	CcSEcCtD
Theophylline—Headache—Triamcinolone—multiple sclerosis	0.000174	0.00162	CcSEcCtD
Theophylline—Headache—Methylprednisolone—multiple sclerosis	0.000174	0.00161	CcSEcCtD
Theophylline—Abdominal pain—Prednisone—multiple sclerosis	0.000174	0.00161	CcSEcCtD
Theophylline—Body temperature increased—Prednisone—multiple sclerosis	0.000174	0.00161	CcSEcCtD
Theophylline—Diarrhoea—Dexamethasone—multiple sclerosis	0.000173	0.0016	CcSEcCtD
Theophylline—Diarrhoea—Betamethasone—multiple sclerosis	0.000173	0.0016	CcSEcCtD
Theophylline—Hypotension—Methotrexate—multiple sclerosis	0.000172	0.00159	CcSEcCtD
Theophylline—Dizziness—Betamethasone—multiple sclerosis	0.000167	0.00155	CcSEcCtD
Theophylline—Dizziness—Dexamethasone—multiple sclerosis	0.000167	0.00155	CcSEcCtD
Theophylline—Insomnia—Methotrexate—multiple sclerosis	0.000166	0.00154	CcSEcCtD
Theophylline—Nausea—Triamcinolone—multiple sclerosis	0.000165	0.00153	CcSEcCtD
Theophylline—Nausea—Methylprednisolone—multiple sclerosis	0.000165	0.00153	CcSEcCtD
Theophylline—Hypersensitivity—Prednisone—multiple sclerosis	0.000162	0.0015	CcSEcCtD
Theophylline—Vomiting—Betamethasone—multiple sclerosis	0.000161	0.00149	CcSEcCtD
Theophylline—Vomiting—Dexamethasone—multiple sclerosis	0.000161	0.00149	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—multiple sclerosis	0.00016	0.00148	CcSEcCtD
Theophylline—Rash—Dexamethasone—multiple sclerosis	0.000159	0.00148	CcSEcCtD
Theophylline—Rash—Betamethasone—multiple sclerosis	0.000159	0.00148	CcSEcCtD
Theophylline—Dermatitis—Betamethasone—multiple sclerosis	0.000159	0.00148	CcSEcCtD
Theophylline—Dermatitis—Dexamethasone—multiple sclerosis	0.000159	0.00148	CcSEcCtD
Theophylline—Headache—Dexamethasone—multiple sclerosis	0.000158	0.00147	CcSEcCtD
Theophylline—Headache—Betamethasone—multiple sclerosis	0.000158	0.00147	CcSEcCtD
Theophylline—Pruritus—Prednisone—multiple sclerosis	0.000156	0.00144	CcSEcCtD
Theophylline—Diarrhoea—Prednisone—multiple sclerosis	0.000151	0.0014	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00015	0.00139	CcSEcCtD
Theophylline—Nausea—Dexamethasone—multiple sclerosis	0.00015	0.00139	CcSEcCtD
Theophylline—Nausea—Betamethasone—multiple sclerosis	0.00015	0.00139	CcSEcCtD
Theophylline—Urticaria—Methotrexate—multiple sclerosis	0.000146	0.00135	CcSEcCtD
Theophylline—Dizziness—Prednisone—multiple sclerosis	0.000145	0.00135	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—multiple sclerosis	0.000145	0.00135	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—multiple sclerosis	0.000145	0.00135	CcSEcCtD
Theophylline—Vomiting—Prednisone—multiple sclerosis	0.00014	0.0013	CcSEcCtD
Theophylline—Rash—Prednisone—multiple sclerosis	0.000139	0.00129	CcSEcCtD
Theophylline—Dermatitis—Prednisone—multiple sclerosis	0.000139	0.00129	CcSEcCtD
Theophylline—Headache—Prednisone—multiple sclerosis	0.000138	0.00128	CcSEcCtD
Theophylline—Hypersensitivity—Methotrexate—multiple sclerosis	0.000135	0.00126	CcSEcCtD
Theophylline—Nausea—Prednisone—multiple sclerosis	0.000131	0.00121	CcSEcCtD
Theophylline—Pruritus—Methotrexate—multiple sclerosis	0.00013	0.00121	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—multiple sclerosis	0.000126	0.00117	CcSEcCtD
Theophylline—Dizziness—Methotrexate—multiple sclerosis	0.000122	0.00113	CcSEcCtD
Theophylline—Vomiting—Methotrexate—multiple sclerosis	0.000117	0.00108	CcSEcCtD
Theophylline—Rash—Methotrexate—multiple sclerosis	0.000116	0.00108	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—multiple sclerosis	0.000116	0.00107	CcSEcCtD
Theophylline—Headache—Methotrexate—multiple sclerosis	0.000115	0.00107	CcSEcCtD
Theophylline—Nausea—Methotrexate—multiple sclerosis	0.000109	0.00101	CcSEcCtD
Theophylline—PDE4B—Signaling Pathways—CCL5—multiple sclerosis	2.72e-05	0.000181	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—MAPK1—multiple sclerosis	2.69e-05	0.000178	CbGpPWpGaD
Theophylline—HDAC2—Disease—APOE—multiple sclerosis	2.68e-05	0.000178	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—IL2—multiple sclerosis	2.68e-05	0.000177	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CXCL10—multiple sclerosis	2.66e-05	0.000176	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—APOE—multiple sclerosis	2.66e-05	0.000176	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCR5—multiple sclerosis	2.65e-05	0.000176	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SPP1—multiple sclerosis	2.65e-05	0.000176	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—IL2—multiple sclerosis	2.64e-05	0.000175	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CD80—multiple sclerosis	2.63e-05	0.000175	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—RRM1—multiple sclerosis	2.63e-05	0.000174	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL2RA—multiple sclerosis	2.61e-05	0.000173	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.61e-05	0.000173	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.61e-05	0.000173	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—IL2—multiple sclerosis	2.59e-05	0.000172	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.59e-05	0.000172	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.000172	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.000172	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCR5—multiple sclerosis	2.58e-05	0.000171	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—APOE—multiple sclerosis	2.58e-05	0.000171	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SPP1—multiple sclerosis	2.55e-05	0.000169	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL2RA—multiple sclerosis	2.54e-05	0.000169	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—POMC—multiple sclerosis	2.54e-05	0.000168	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—APOE—multiple sclerosis	2.54e-05	0.000168	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.53e-05	0.000168	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—IL2—multiple sclerosis	2.52e-05	0.000167	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SPP1—multiple sclerosis	2.52e-05	0.000167	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—POMC—multiple sclerosis	2.5e-05	0.000166	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCR5—multiple sclerosis	2.48e-05	0.000165	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CCL2—multiple sclerosis	2.48e-05	0.000165	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCL10—multiple sclerosis	2.47e-05	0.000164	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCR5—multiple sclerosis	2.45e-05	0.000163	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—BCHE—multiple sclerosis	2.45e-05	0.000163	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL2RA—multiple sclerosis	2.45e-05	0.000162	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCL2—multiple sclerosis	2.45e-05	0.000162	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—IL2—multiple sclerosis	2.43e-05	0.000161	CbGpPWpGaD
Theophylline—HDAC2—Disease—CD80—multiple sclerosis	2.42e-05	0.000161	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SRM—multiple sclerosis	2.42e-05	0.000161	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL2RA—multiple sclerosis	2.42e-05	0.00016	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—APOE—multiple sclerosis	2.41e-05	0.00016	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.41e-05	0.00016	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CD80—multiple sclerosis	2.4e-05	0.000159	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—IL2—multiple sclerosis	2.4e-05	0.000159	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—MAPK1—multiple sclerosis	2.4e-05	0.000159	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.39e-05	0.000158	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.000157	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—APOE—multiple sclerosis	2.35e-05	0.000156	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CD80—multiple sclerosis	2.33e-05	0.000155	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CD86—multiple sclerosis	2.33e-05	0.000154	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CD80—multiple sclerosis	2.29e-05	0.000152	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCL5—multiple sclerosis	2.29e-05	0.000152	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—POMC—multiple sclerosis	2.28e-05	0.000151	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—APOE—multiple sclerosis	2.26e-05	0.00015	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—TYK2—multiple sclerosis	2.25e-05	0.000149	CbGpPWpGaD
Theophylline—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.25e-05	0.000149	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCL2—multiple sclerosis	2.23e-05	0.000148	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—APOE—multiple sclerosis	2.23e-05	0.000148	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TYK2—multiple sclerosis	2.22e-05	0.000147	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—POMC—multiple sclerosis	2.21e-05	0.000147	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.21e-05	0.000147	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.21e-05	0.000147	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.19e-05	0.000145	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CD80—multiple sclerosis	2.18e-05	0.000145	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—POMC—multiple sclerosis	2.18e-05	0.000144	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCL2—multiple sclerosis	2.17e-05	0.000144	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CD86—multiple sclerosis	2.16e-05	0.000143	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.16e-05	0.000143	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCL2—multiple sclerosis	2.13e-05	0.000141	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCL5—multiple sclerosis	2.13e-05	0.000141	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CD80—multiple sclerosis	2.12e-05	0.000141	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SPP1—multiple sclerosis	2.12e-05	0.000141	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—MAPK1—multiple sclerosis	2.12e-05	0.000141	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—MAPK1—multiple sclerosis	2.09e-05	0.000138	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—POMC—multiple sclerosis	2.07e-05	0.000137	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—IL2—multiple sclerosis	2.07e-05	0.000137	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCR5—multiple sclerosis	2.06e-05	0.000137	CbGpPWpGaD
Theophylline—HDAC2—Disease—TYK2—multiple sclerosis	2.05e-05	0.000136	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CD80—multiple sclerosis	2.04e-05	0.000135	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.04e-05	0.000135	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL2RA—multiple sclerosis	2.03e-05	0.000135	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TYK2—multiple sclerosis	2.03e-05	0.000135	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCL2—multiple sclerosis	2.03e-05	0.000135	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.02e-05	0.000134	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CD80—multiple sclerosis	2.02e-05	0.000134	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—POMC—multiple sclerosis	2.02e-05	0.000134	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—MAPK1—multiple sclerosis	1.98e-05	0.000132	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.98e-05	0.000131	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCL2—multiple sclerosis	1.97e-05	0.000131	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SPP1—multiple sclerosis	1.97e-05	0.000131	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TYK2—multiple sclerosis	1.97e-05	0.00013	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.96e-05	0.00013	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—POMC—multiple sclerosis	1.94e-05	0.000129	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TYK2—multiple sclerosis	1.94e-05	0.000128	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—MAPK1—multiple sclerosis	1.93e-05	0.000128	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—POMC—multiple sclerosis	1.92e-05	0.000127	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCR5—multiple sclerosis	1.92e-05	0.000127	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCL2—multiple sclerosis	1.9e-05	0.000126	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.89e-05	0.000125	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCL2—multiple sclerosis	1.88e-05	0.000124	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—APOE—multiple sclerosis	1.88e-05	0.000124	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL2—multiple sclerosis	1.88e-05	0.000124	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.87e-05	0.000124	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—MAPK1—multiple sclerosis	1.86e-05	0.000123	CbGpPWpGaD
Theophylline—HDAC2—Disease—CD4—multiple sclerosis	1.85e-05	0.000123	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL2—multiple sclerosis	1.85e-05	0.000123	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TYK2—multiple sclerosis	1.84e-05	0.000122	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—IL6—multiple sclerosis	1.84e-05	0.000122	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—MAPK1—multiple sclerosis	1.84e-05	0.000122	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TYK2—multiple sclerosis	1.79e-05	0.000119	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.75e-05	0.000116	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MMP9—multiple sclerosis	1.75e-05	0.000116	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—APOE—multiple sclerosis	1.74e-05	0.000116	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TYK2—multiple sclerosis	1.72e-05	0.000114	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.71e-05	0.000113	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.71e-05	0.000113	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TYK2—multiple sclerosis	1.7e-05	0.000113	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CD80—multiple sclerosis	1.7e-05	0.000113	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL2—multiple sclerosis	1.69e-05	0.000112	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—IL6—multiple sclerosis	1.68e-05	0.000111	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.68e-05	0.000111	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL2—multiple sclerosis	1.64e-05	0.000109	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—IL6—multiple sclerosis	1.63e-05	0.000108	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—POMC—multiple sclerosis	1.61e-05	0.000107	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL2—multiple sclerosis	1.61e-05	0.000107	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.61e-05	0.000107	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—IL6—multiple sclerosis	1.6e-05	0.000106	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.6e-05	0.000106	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MMP9—multiple sclerosis	1.6e-05	0.000106	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.6e-05	0.000106	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCL2—multiple sclerosis	1.58e-05	0.000105	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CD80—multiple sclerosis	1.58e-05	0.000105	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.56e-05	0.000104	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—STAT3—multiple sclerosis	1.56e-05	0.000103	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MMP9—multiple sclerosis	1.55e-05	0.000103	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL2—multiple sclerosis	1.53e-05	0.000102	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—IL6—multiple sclerosis	1.53e-05	0.000101	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MMP9—multiple sclerosis	1.52e-05	0.000101	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.52e-05	0.000101	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.0001	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—POMC—multiple sclerosis	1.5e-05	9.94e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL2—multiple sclerosis	1.49e-05	9.89e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—IL6—multiple sclerosis	1.48e-05	9.84e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—APOE—multiple sclerosis	1.47e-05	9.78e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCL2—multiple sclerosis	1.47e-05	9.72e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.46e-05	9.71e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MMP9—multiple sclerosis	1.45e-05	9.62e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MYC—multiple sclerosis	1.45e-05	9.59e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TGFB1—multiple sclerosis	1.44e-05	9.57e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL2—multiple sclerosis	1.44e-05	9.52e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.43e-05	9.51e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—MYC—multiple sclerosis	1.43e-05	9.51e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TYK2—multiple sclerosis	1.43e-05	9.5e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—STAT3—multiple sclerosis	1.43e-05	9.5e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—IL6—multiple sclerosis	1.43e-05	9.47e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—STAT3—multiple sclerosis	1.42e-05	9.42e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL2—multiple sclerosis	1.42e-05	9.4e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MAPK1—multiple sclerosis	1.42e-05	9.38e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MMP9—multiple sclerosis	1.41e-05	9.36e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—IL6—multiple sclerosis	1.41e-05	9.36e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.38e-05	9.18e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—STAT3—multiple sclerosis	1.38e-05	9.13e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MMP9—multiple sclerosis	1.36e-05	9.01e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—STAT3—multiple sclerosis	1.36e-05	8.99e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MMP9—multiple sclerosis	1.34e-05	8.9e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TYK2—multiple sclerosis	1.33e-05	8.83e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—MYC—multiple sclerosis	1.33e-05	8.83e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—TGFB1—multiple sclerosis	1.33e-05	8.8e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MYC—multiple sclerosis	1.32e-05	8.75e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TGFB1—multiple sclerosis	1.32e-05	8.73e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	8.67e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—MAPK1—multiple sclerosis	1.3e-05	8.63e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.3e-05	8.62e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.29e-05	8.58e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MAPK1—multiple sclerosis	1.29e-05	8.56e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—STAT3—multiple sclerosis	1.29e-05	8.55e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MYC—multiple sclerosis	1.28e-05	8.49e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TGFB1—multiple sclerosis	1.28e-05	8.47e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—POMC—multiple sclerosis	1.27e-05	8.4e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MYC—multiple sclerosis	1.26e-05	8.35e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TGFB1—multiple sclerosis	1.26e-05	8.33e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—STAT3—multiple sclerosis	1.25e-05	8.32e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MAPK1—multiple sclerosis	1.25e-05	8.3e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MAPK1—multiple sclerosis	1.23e-05	8.17e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—STAT3—multiple sclerosis	1.21e-05	8.01e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MYC—multiple sclerosis	1.2e-05	7.95e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TGFB1—multiple sclerosis	1.2e-05	7.93e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—STAT3—multiple sclerosis	1.19e-05	7.91e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL2—multiple sclerosis	1.19e-05	7.9e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.19e-05	7.9e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MAPK1—multiple sclerosis	1.17e-05	7.77e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MYC—multiple sclerosis	1.17e-05	7.73e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TGFB1—multiple sclerosis	1.16e-05	7.71e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ALB—multiple sclerosis	1.16e-05	7.66e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MAPK1—multiple sclerosis	1.14e-05	7.56e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.14e-05	7.54e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—multiple sclerosis	1.13e-05	7.48e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.13e-05	7.47e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—multiple sclerosis	1.12e-05	7.44e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TGFB1—multiple sclerosis	1.12e-05	7.42e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	7.41e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—multiple sclerosis	1.11e-05	7.35e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2—multiple sclerosis	1.11e-05	7.35e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TGFB1—multiple sclerosis	1.11e-05	7.34e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—multiple sclerosis	1.1e-05	7.31e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MAPK1—multiple sclerosis	1.1e-05	7.28e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—multiple sclerosis	1.09e-05	7.21e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-05	7.19e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—multiple sclerosis	1.05e-05	6.95e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	6.75e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—multiple sclerosis	1e-05	6.65e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—multiple sclerosis	1e-05	6.63e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—multiple sclerosis	9.92e-06	6.58e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—APOE—multiple sclerosis	9.63e-06	6.39e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.63e-06	6.38e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—multiple sclerosis	9.62e-06	6.38e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—multiple sclerosis	9.47e-06	6.28e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—multiple sclerosis	9.33e-06	6.18e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—multiple sclerosis	9.32e-06	6.18e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—multiple sclerosis	9.3e-06	6.17e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK1—multiple sclerosis	9.12e-06	6.05e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—APOE—multiple sclerosis	9.08e-06	6.02e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—multiple sclerosis	9.01e-06	5.97e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—multiple sclerosis	8.76e-06	5.81e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—multiple sclerosis	8.66e-06	5.75e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—multiple sclerosis	8.64e-06	5.73e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK1—multiple sclerosis	8.48e-06	5.62e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—multiple sclerosis	8.44e-06	5.59e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—multiple sclerosis	8.34e-06	5.53e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—APOE—multiple sclerosis	8.33e-06	5.52e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—POMC—multiple sclerosis	8.28e-06	5.49e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—POMC—multiple sclerosis	7.8e-06	5.17e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—multiple sclerosis	7.55e-06	5e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.43e-06	4.93e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—POMC—multiple sclerosis	7.15e-06	4.74e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—multiple sclerosis	7.11e-06	4.72e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—multiple sclerosis	7.01e-06	4.65e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—APOE—multiple sclerosis	6.84e-06	4.53e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—APOE—multiple sclerosis	6.78e-06	4.49e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—multiple sclerosis	6.52e-06	4.32e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—multiple sclerosis	6.51e-06	4.32e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—POMC—multiple sclerosis	5.87e-06	3.89e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—POMC—multiple sclerosis	5.82e-06	3.86e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOE—multiple sclerosis	5.79e-06	3.84e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—multiple sclerosis	5.35e-06	3.55e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—multiple sclerosis	5.31e-06	3.52e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—POMC—multiple sclerosis	4.98e-06	3.3e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—multiple sclerosis	4.54e-06	3.01e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOE—multiple sclerosis	4.47e-06	2.96e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—POMC—multiple sclerosis	3.84e-06	2.55e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—multiple sclerosis	3.5e-06	2.32e-05	CbGpPWpGaD
